Study finds that diabetes may hasten breast cancer tumor growth and stiffness

byVanderbilt UniversityHyperglycemia increases tumor growth through promoting cell proliferation. (A) Weekly average tumor volume measurements for nondiabetic (Ctrl), diabetic (STZ), and diabeti

Updated on: January 23,2024 18

Study finds that diabetes may hasten breast cancer tumor growth and stiffness

byVanderbilt UniversityHyperglycemia increases tumor growth through promoting cell proliferation. (A) Weekly average tumor volume measurements for nondiabetic (Ctrl), diabetic (STZ), and diabeti

Updated on:January 23,2024 18

Climbing a new path allows chemists to ascend cancer's steepest research challenge, a gene called MYC

byUniversity of FloridaA "fishing hook" molecule in red is added to a drug-like compound to catch enzymes that chop up RNA, yellow, for recycling by cells. The strategy has been used t

Updated on: January 16,2024 15

Climbing a new path allows chemists to ascend cancer's steepest research challenge, a gene called MYC

byUniversity of FloridaA "fishing hook" molecule in red is added to a drug-like compound to catch enzymes that chop up RNA, yellow, for recycling by cells. The strategy has been used t

Updated on:January 16,2024 15

Variation in cancer-causing KRAS mutations greater than thought

by University of Eastern FinlandA mutation at the amino acid glycine 12 (orange) of the KRAS protein (purple) has an effect on KRAS dynamics. Credit: Tatu PantsarThe effects of KRAS mutations und

Updated on: April 09,2024 19

Variation in cancer-causing KRAS mutations greater than thought

by University of Eastern FinlandA mutation at the amino acid glycine 12 (orange) of the KRAS protein (purple) has an effect on KRAS dynamics. Credit: Tatu PantsarThe effects of KRAS mutations und

Updated on:April 09,2024 19

Early findings suggest clinical and lab-based approach critical to tracking head and neck cancer recurrence

by Anna Megdell,University of MichiganSurvival over time. (A)Median overall survival (mOS) plotted over years of the study. (B)mOS improved from 1998 to 2007 to 2008–2019. (C)m

Updated on: January 30,2024 11

Early findings suggest clinical and lab-based approach critical to tracking head and neck cancer recurrence

by Anna Megdell,University of MichiganSurvival over time. (A)Median overall survival (mOS) plotted over years of the study. (B)mOS improved from 1998 to 2007 to 2008–2019. (C)m

Updated on:January 30,2024 11

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Updated on: March 09,2024 20

Current PSA monitoring ignores risk to some prostate cancer survivors

by Scott Maier,University of California, San FranciscoCredit: University of California, San FranciscoProstate cancer survivors make up the largest group, 41 percent, of male cancer survivors. In

Updated on:March 09,2024 20

Mouse study suggests new therapeutic strategy to reduce cardiovascular disease in cancer survivors

byRockefeller University PressA mouse model of cardiac toxicity following DNA damage. (A) Schematic representation of experimental model of radiation-induced cardiac toxicity and timeline cardio

Updated on: January 11,2024 10

Mouse study suggests new therapeutic strategy to reduce cardiovascular disease in cancer survivors

byRockefeller University PressA mouse model of cardiac toxicity following DNA damage. (A) Schematic representation of experimental model of radiation-induced cardiac toxicity and timeline cardio

Updated on:January 11,2024 10

Researchers publish consensus statement on patient selection and appropriate use of Lu-177 PSMA-617 radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingProstate cancer cells. Credit: NIH Image GalleryThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement t

Updated on: February 20,2024 14

Researchers publish consensus statement on patient selection and appropriate use of Lu-177 PSMA-617 radionuclide therapy

by Society of Nuclear Medicine and Molecular ImagingProstate cancer cells. Credit: NIH Image GalleryThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) has issued a new consensus statement t

Updated on:February 20,2024 14

Study identifies molecular differences between primary breast cancer and its metastases

by UNC Lineberger Comprehensive Cancer CenterStudy design and global genomic patterns of metastatic breast tumors. a, Cohort description of the AURORA Metastatic Project. b, Diagram of the shared

Updated on: February 20,2024 14

Study identifies molecular differences between primary breast cancer and its metastases

by UNC Lineberger Comprehensive Cancer CenterStudy design and global genomic patterns of metastatic breast tumors. a, Cohort description of the AURORA Metastatic Project. b, Diagram of the shared

Updated on:February 20,2024 14

Protein discovery sparks treatment hope for aggressive cancer

by Walter and Eliza Hall Institute of Medical ResearchTreating acute lymphoblastic leukaemia cells with the drug CX-5461 disrupts the nucleolar ribosome machinery shown by the fibrillarin protein

Updated on: March 20,2024 15

Protein discovery sparks treatment hope for aggressive cancer

by Walter and Eliza Hall Institute of Medical ResearchTreating acute lymphoblastic leukaemia cells with the drug CX-5461 disrupts the nucleolar ribosome machinery shown by the fibrillarin protein

Updated on:March 20,2024 15

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

Updated on: March 01,2024 16

New chemical weapon to combat cancer

by University of GenevaMultipolar melanoma cells stained for centrosomes (gamma-tubulin in red, centrin in green) and DNA (DAPI in blue). Scale bar represents 5 µm. Credit: UNIGEUNIGE researchers

Updated on:March 01,2024 16

After testicular cancer is cured, remain alert in the future

by University of Rochester Medical CenterBecause testicular cancer has a 95 percent cure rate, it is easier for men to move on and forget about it. But new research in theJournal of Clinica

Updated on: March 01,2024 15

After testicular cancer is cured, remain alert in the future

by University of Rochester Medical CenterBecause testicular cancer has a 95 percent cure rate, it is easier for men to move on and forget about it. But new research in theJournal of Clinica

Updated on:March 01,2024 15

New calculation tool identifies a group of cancer patients with favorable prognosis

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraResearchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myelo

Updated on: January 12,2024 15

New calculation tool identifies a group of cancer patients with favorable prognosis

by Centro de Investigación Médica Aplicada (CIMA) Universidad de NavarraResearchers from Cima and Clinica University of Navarra have developed a calculator that identifies patients with multiple myelo

Updated on:January 12,2024 15